Internal Medicine, Infectious Disease · Oklahoma City, OK
NPI
1013017292
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
1111 N Lee Ave Ste 249
Oklahoma City, OK, 73103
Phone (405) 594-5848
Groups this clinician bills Medicare through
Medicare paid, 2024
$260K
3,640 services
Medicare patients, 2024
733
Average age 73
Drug cost, 2024
$319K
579 prescriptions
Company payments, 2025
$113
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vijay K Kolli was code 99232 (hospital e&m - subsequent), 2,077 times for 572 patients. In total Vijay K Kolli billed 3,640 services in 22 codes, and Medicare paid $260K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 2,077 | 572 | $58.09 | $121K |
| 99233 Hospital E&M - Subsequent | Facility | 569 | 324 | $87.29 | $50K |
| 99223 Hospital E&M - Initial | Facility | 438 | 392 | $127.47 | $56K |
| 97597 Debridement | Facility | 143 | 49 | $26.23 | $3,750 |
| 99348 Home E&M - New and Established | Office | 66 | 18 | $57.12 | $3,770 |
| 11042 Debridement | Office | 55 | 11 | $83.97 | $4,618 |
| 11042 Debridement | Facility | 37 | 29 | $38.01 | $1,406 |
| 11045 Debridement | Facility | 36 | 12 | $18.66 | $672 |
| 99222 Hospital E&M - Initial | Facility | 20 | 20 | $86.93 | $1,739 |
By year: 2022 $217K for 3,019 services; 2023 $210K for 2,868 services; 2024 $260K for 3,640 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vijay K Kolli prescribed most often to Medicare patients was Piperacillin-Tazobactam (Piperacillin Sodium/Tazobactam), with 107 prescriptions and refills. In total Vijay K Kolli wrote 579 Medicare prescriptions that cost $319K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 107 | 107 | 30 | $16K |
| Ceftriaxone Ceftriaxone Sodium | 106 | 106 | 29 | $22K |
| Ertapenem Ertapenem Sodium | 89 | 89 | 22 | $32K |
| Daptomycin Generic | 87 | 87 | 23 | $68K |
| Cefazolin Sodium Generic | 41 | 41 | 12 | $2,847 |
| Nafcillin Sodium Generic | 32 | 32 | Under 11 | $18K |
| Meropenem Generic | 15 | 15 | Under 11 | $3,341 |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 14 | 14 | Under 11 | $1,680 |
| Prezcobix Darunavir/Cobicistat | 14 | 14 | Under 11 | $32K |
| Ampicillin Sodium Generic | 11 | 11 | Under 11 | $5,029 |
Brand drugs: 36 claims; generic drugs: 543 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vijay K Kolli $113 ($113 in general payments such as food, travel and fees) from 2 companies. The largest payer was Pfizer Inc. with $61.89.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.